Clinical trial
Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome
NCT01077479 is registered in ClinicalTrials.gov with Western Sydney Local Health District as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome
- Lead sponsor
- Western Sydney Local Health District
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- June 30, 2013
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.